Pearl of the Month

Not your ordinary neuropathy


 

Pearl

Strongly consider treatment induced neuropathy in your patients with diabetes who present with acute painful neuropathy and/or autonomic dysfunction in the setting of rapid improvement of glucose control.

Dr. Paauw is professor of medicine in the division of general internal medicine at the University of Washington, Seattle, and serves as third-year medical student clerkship director at the University of Washington. He is a member of the editorial advisory board of Internal Medicine News. Dr. Paauw has no conflicts to disclose. Contact him at imnews@mdedge.com.

References

1. American Diabetes Association. Diabetes Care. 2019 Jan;42(Suppl 1):S90-102.

2. Gibbons CH and Freeman R. Ann Neurol 2010; 67:534–41.

3. Gibbons CH and Freeman R. Brain. 2015;138:43-52.

4. Siddique N et al. Endocrinol Diabetes Metab Case Rep. 2020 Feb 26;2020:19-0140.

Pages

Recommended Reading

Geriatric patients: My three rules for them
MDedge Neurology
Diabetic neuropathic pain linked to brain bioenergic anomalies
MDedge Neurology
COVID-19 antibody response not reduced with diabetes
MDedge Neurology
Diabetic retinopathy may predict greater risk of COVID-19 severity
MDedge Neurology
Prioritize COVID-19 vaccination in both types of diabetes, say docs
MDedge Neurology
Opioids prescribed for diabetic neuropathy pain, against advice
MDedge Neurology
‘Major update’ of BP guidance for kidney disease; treat to 120 mm Hg
MDedge Neurology
Type 2 diabetes linked to increased risk for Parkinson’s
MDedge Neurology
High obesity rates in Southern states magnify COVID threats
MDedge Neurology
Prediabetes linked to higher CVD and CKD rates
MDedge Neurology